# Safety & Clinical Performance Study of Catheter Ablation With the Centauri System for Patients With Atrial Fibrillation

Study · id `cardio:ct-nct04523545` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04523545](<https://clinicaltrials.gov/study/NCT04523545>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT04523545

Browse, organ or system: Heart  
Browse, condition area: Stroke; Heart rhythm problems  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 200 participants.

## Technical summary

Registry record NCT04523545. Allocation not applicable; no masking; primary purpose treatment. Start 2020-09-28 (actual); primary completion 2023-04 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 200 participants (planned count; ClinicalTrials.gov record NCT04523545, source copy `cardio:ctgov-nct04523545-2022-08-22`, retrieved 2026-10-26)
- Started: 2020-09-28 (actual) (ClinicalTrials.gov record NCT04523545, source copy `cardio:ctgov-nct04523545-2022-08-22`, retrieved 2026-10-26)
- Primary completion: 2023-04 (anticipated) (ClinicalTrials.gov record NCT04523545, source copy `cardio:ctgov-nct04523545-2022-08-22`, retrieved 2026-10-26)
- Completion: 2023-04 (anticipated) (ClinicalTrials.gov record NCT04523545, source copy `cardio:ctgov-nct04523545-2022-08-22`, retrieved 2026-10-26)
- Countries: Croatia (ClinicalTrials.gov record NCT04523545, source copy `cardio:ctgov-nct04523545-2022-08-22`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04523545-2022-08-22`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety & Clinical Performance Study of Catheter Ablation With the Centauri System for Patients With Atrial Fibrillation
- Acronym: ECLIPSE AF
- Condition: Atrial Fibrillation
- Intervention (Device): cardiac ablation
- Lead sponsor: Galaxy Medical, Inc.
- Lead sponsor class: INDUSTRY

## Connected pages

- Registry condition terms include this condition: Arrhythmia (heart rhythm problems) (`cardio:arrhythmia`)
- Registry condition terms include this condition: Atrial fibrillation (AF) (`cardio:atrial-fibrillation`)

## Provenance

Content hash: 2e5c75852290cae529ebdbb2ed1bb349bfb756f959456a7835d3854e6134d9d4
Last substantive edit: 2026-10-26
Evidence last checked: Not recorded
